Purpose

The researchers propose a three-arm pilot study of Mindfulness-Based Cognitive Therapy (MBCT) delivered via telephone (MBCT-T), video (MBCT-V) or Enhanced Usual Care (EUC).

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Currently meets ICHD-3 (International Classification for Headache Disorders - 3rd Edition) criteria for migraine using the American Migraine Prevalence and Prevention Diagnostic Module - Self-reported 4-14 headache days per month, with at least one attack meeting migraine criteria - Score between 5-14 on the PHQ-9 (Patient Health Questionnaire) - Age ≥ 18 - Ability to read and speak English - Capacity to consent - Prospective diary-confirmed 4-14 headache days per month, with at least one attack meeting migraine criteria - ≥1 year of migraine

Exclusion Criteria

  • Meeting ICHD-3 criteria for persistent headache attributed to traumatic injury to the head (post-traumatic headache) on the American Migraine Prevalence and Prevention Diagnostic Module - Changes in preventive migraine medication or anti-depressant medication within 6 weeks of intake - Changes in longer-term migraine prevention (onabotulinum toxin A, injectable or oral anti-calcitonin gene related peptide treatment; neuromodulatory device) within 3 months of intake - Changes in acute migraine treatment started within 4 weeks of enrollment - Comorbid psychiatric illness or clinical features that would interfere with participant's ability to participate in or receive benefit from the intervention, including but not limited to: active suicidal ideation; recent history of psychosis or mania; borderline, histrionic or narcissistic personality disorder; cognitive impairment; sensory disabilities; bipolar disorder; obsessive-compulsive disorder, drug use - Prior history of engaging in formal mindfulness-based interventions including: MBSR (Mindfulness-based stress reduction), MBCT (Mindfulness-based cognitive therapy), Acceptance and Commitment therapy, Dialectical Behavior Therapy - Current daily meditation practice - Inability to adhere to headache diary during baseline evaluation period (recorded fewer than 25/28 days) - Unwilling to maintain stable current acute or preventive medication dosages for study duration - Any condition that would prevent being a suitable candidate or interfere with medical care needs

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Arm Groups

ArmDescriptionAssigned Intervention
Active Comparator
MBCT-Telephone
8 weekly classes delivered via telephone.
  • Behavioral: MBCT-Telephone
    Classes follow MBCT protocol delivered via telephone by a master's level or higher mental health provider under the supervision of a licensed clinical psychologist, following treatment fidelity guidelines from NIH's Behavioral Change Consortium.
Active Comparator
MBCT-Video
8 weekly classes delivered via video.
  • Behavioral: MBCT-Video
    Classes follow MBCT protocol delivered via video by a master's level or higher mental health provider under the supervision of a licensed clinical psychologist, following treatment fidelity guidelines from NIH's Behavioral Change Consortium.
Active Comparator
Enhanced Usual Care (EUC)
8 weekly online modules delivered via web portal.
  • Behavioral: Enhanced Usual Care (EUC)
    Weekly online modules follow migraine and behavior principles delivered via web portal developed by a team of licensed clinical psychologists, neurologists, and mental health providers.

Recruiting Locations

More Details

Status
Recruiting
Sponsor
Amanda Shallcross

Study Contact

Narissa McCarty, MS
(216) 780-1931
mccartn3@ccf.org

Detailed Description

This study aims to set the stage for a future definitive large-scale Phase III trial in patients with migraine and depressive symptoms. This pilot is aimed at evaluating the feasibility and acceptability of the Telephone and Video MBCT and EUC in people with migraine (defined by the International Classification of Headache Disorders - 3) and depressive symptoms (defined by empirical cut-offs on the Patient Health Questionnaire - 9).

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.